Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ab4ac9c866cc459ead9bf00b13aabf85 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ab4ac9c866cc459ead9bf00b13aabf852021-12-01T19:10:50ZEvaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments2296-418510.3389/fbioe.2021.779018https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf852021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.779018/fullhttps://doaj.org/toc/2296-4185Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation. Protease-digested lactoferrin fragments often exhibit improved therapeutic properties compared to full-length lactoferrin (flHLF). However, there are no studies on the use of protease-digested lactoferrin fragments to treat inflammation. Herein, we assess the anti-inflammatory properties of engineered recombinant lactoferrin fragments (rtHLF4, rteHLF1, and rpHLF2) on non-malignant colonic fibroblast cells and colorectal cancer cells. We found that rtHLF4 is 10 times more effective to prevent inflammation compared to flHLF. These results were investigated by looking into the reactive oxygen species (ROS) production, angiogenesis activity, and cellular proliferation of the treated cells. We have demonstrated in this study the anti-inflammatory properties of the flHLF and the various lactoferrin fragments. These results complement the anti-cancer properties of these proteins that were demonstrated in an earlier study.Yu PanZhao LiuYijie WangLinshen ZhangNiying ChuaLei DaiJun ChenChun Loong HoFrontiers Media S.A.articlelactoferrinanti-infammatoryprotease-digestednon-malignant colonic fibroblasts cellstNF-alphaBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
lactoferrin anti-infammatory protease-digested non-malignant colonic fibroblasts cells tNF-alpha Biotechnology TP248.13-248.65 |
spellingShingle |
lactoferrin anti-infammatory protease-digested non-malignant colonic fibroblasts cells tNF-alpha Biotechnology TP248.13-248.65 Yu Pan Zhao Liu Yijie Wang Linshen Zhang Niying Chua Lei Dai Jun Chen Chun Loong Ho Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
description |
Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation. Protease-digested lactoferrin fragments often exhibit improved therapeutic properties compared to full-length lactoferrin (flHLF). However, there are no studies on the use of protease-digested lactoferrin fragments to treat inflammation. Herein, we assess the anti-inflammatory properties of engineered recombinant lactoferrin fragments (rtHLF4, rteHLF1, and rpHLF2) on non-malignant colonic fibroblast cells and colorectal cancer cells. We found that rtHLF4 is 10 times more effective to prevent inflammation compared to flHLF. These results were investigated by looking into the reactive oxygen species (ROS) production, angiogenesis activity, and cellular proliferation of the treated cells. We have demonstrated in this study the anti-inflammatory properties of the flHLF and the various lactoferrin fragments. These results complement the anti-cancer properties of these proteins that were demonstrated in an earlier study. |
format |
article |
author |
Yu Pan Zhao Liu Yijie Wang Linshen Zhang Niying Chua Lei Dai Jun Chen Chun Loong Ho |
author_facet |
Yu Pan Zhao Liu Yijie Wang Linshen Zhang Niying Chua Lei Dai Jun Chen Chun Loong Ho |
author_sort |
Yu Pan |
title |
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
title_short |
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
title_full |
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
title_fullStr |
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
title_full_unstemmed |
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments |
title_sort |
evaluation of the anti-inflammatory and anti-oxidative effects of therapeutic human lactoferrin fragments |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf85 |
work_keys_str_mv |
AT yupan evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT zhaoliu evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT yijiewang evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT linshenzhang evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT niyingchua evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT leidai evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT junchen evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments AT chunloongho evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments |
_version_ |
1718404648180645888 |